Stage-dependent prognostic value of systemic inflammatory biomarkers in early triple-negative breast cancer (TNBC)

被引:0
|
作者
Marta, G. Nader [1 ]
Tiecher, R. Dahmer [1 ]
Vicentini, M. F. Batistuzzo [1 ]
Dornellas, A. [1 ]
Hoff, P. M. [1 ]
Testa, L. [1 ]
机构
[1] ICESP Inst Canc Estado Sao Paulo, Dept Med Oncol, Sao Paulo, Brazil
关键词
D O I
10.1016/j.annonc.2021.08.453
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
172P
引用
收藏
页码:S434 / S434
页数:1
相关论文
共 50 条
  • [41] Information preferences of women with triple-negative breast cancer (TNBC).
    Swiger, Kathleen Dickerson
    Sendecki, Jocelyn A.
    Guglielmino, Janine E.
    Rugo, Hope S.
    Domchek, Susan M.
    Anders, Carey K.
    Stricker, Carrie Tompkins
    Nelson, Hillary C. M.
    Hanson, Arin Ahlum
    Dinerman, Hayley
    Henry, Catherine Creme
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] The prognostic value of stem cell markers in triple-negative breast cancer
    Almasi, Szintia
    Nagy, Agnes
    Krenacs, Tibor
    Lantos, Tamas
    Zombori, Tamas
    Cserni, Gabor
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [43] Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
    Collina, Francesca
    Di Bonito, Maurizio
    Li Bergolis, Valeria
    De laurentiis, Michelino
    Vitagliano, Carlo
    Cerrone, Margherita
    Nuzzo, Francesco
    Cantile, Monica
    Botti, Gerardo
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [44] Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC)
    Mishra, Anjali
    Mishra, Shravan Kumar
    Sharanappa, Vikram
    Krishnani, Narendra
    Kumari, Niraj
    Agarwal, Gaurav
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (02) : 250 - 257
  • [45] Does triple-negative breast cancer (TNBC) have distinct clinicopathologic characteristics and prognostic significance?
    Rhee, J.
    Oh, S.
    Oh, D.
    Im, S.
    Lee, S.
    Kim, D.
    Heo, D.
    Park, I.
    Bang, Y.
    Kim, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Clinicopathological and Prognostic Characteristics of Triple-Negative Breast Cancer (TNBC) in Chinese Patients: A Retrospective Study
    Li, Chun-Yan
    Zhang, Sheng
    Zhang, Xiao-Bei
    Wang, Pei
    Hou, Guo-Fang
    Zhang, Jin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3779 - 3784
  • [47] Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC)
    Anjali Mishra
    Shravan Kumar Mishra
    Vikram Sharanappa
    Narendra Krishnani
    Niraj Kumari
    Gaurav Agarwal
    Indian Journal of Surgical Oncology, 2024, 15 : 250 - 257
  • [48] Identification of immune-related prognostic biomarkers in triple-negative breast cancer
    Song, Xiao-Qing
    Shao, Zhi-Ming
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (04)
  • [49] KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer
    Takuya Nagata
    Yutaka Shimada
    Shinichi Sekine
    Makoto Moriyama
    Isaya Hashimoto
    Koshi Matsui
    Tomoyuki Okumura
    Takashi Hori
    Johji Imura
    Kazuhiro Tsukada
    Breast Cancer, 2017, 24 : 326 - 335
  • [50] Prognostic value of histopathology, stromal tumor infiltrating lymphocytes (sTILs) and adjuvant chemotherapy (AdjCT) in early stage triple negative breast cancer (TNBC).
    Leon-Ferre, Roberto Antonio
    Polley, Mei-Yin
    Liu, Heshan
    Gilbert, Judith A.
    Cafourek, Victoria
    Hillman, David W.
    Elkhanany, Ahmed
    Akinhanmi, Margaret
    Negron, Vivian
    Boughey, Judy Caroline
    Liu, Minetta C.
    Ingle, James N.
    Kalari, Krishna R.
    Couch, Fergus
    Visscher, Daniel W.
    Goetz, Matthew P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35